Sarcoma trials in Argentina
5 trials · From ClinicalTrials.gov, checked 10 November 2026. Ask the study team whether a trial fits you.
- Phase 3Taking peopleA Study to Evaluate the Efficacy and Safety of Divarasib Compared With Investigator's Choice of Immunotherapy or Observation in Participants With Resected Stage II-III KRAS G12C-Positive Non-Small Cell Lung Cancer (NSCLC)
- Where
- Capital Federal, Ciudad Autonoma Buenos Aires, Mar del Plata, Rosario
- Age
- 18 years and over
- People
- 400 worldwide
- Run by
- Hoffmann-La Roche
See details and how to joinNCT07541170 · EU 2025-524263-21-01 - Phase 1/2Taking peopleStudy to Test the Safety and Tolerability of PF-07220060 in Participants With Advance Solid Tumors
- Where
- Buenos Aires, Caba, Ciudad Autónoma de Buenos Aires, Córdoba, La Rioja
- Age
- 18 years and over
- People
- 430 worldwide
- Run by
- Pfizer
See details and how to joinNCT04557449 · EU 2024-512120-11-00 - Phase 3Taking peopleA Study of Calderasib (MK-1084) Plus Pembrolizumab (MK-3475) in Participants With KRAS G12C Mutant Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥50% (MK-1084-004/KANDLELIT-004)
- Where
- Berazategui, CABA, Mar del Plata, Rosario, Viedma
- Age
- 18 years and over
- People
- 348 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT06345729 · EU 2023-507776-42-00 - Phase 2Taking peopleA Study of Propranolol to Treat Kaposi Sarcoma
- Where
- Buenos Aires
- People
- 25 worldwide
- Run by
- AIDS Malignancy Consortium
See details and how to joinNCT05797662 - No phaseTaking peopleObservational Study, for Quality Assessment, of Sarcoma in European and Latin American Multidisciplinary NETWORK
- Where
- Buenos Aires
- Age
- 18 years to 120 years
- People
- 5,000 worldwide
- Run by
- Grupo Espanol de Investigacion en Sarcomas
See details and how to joinNCT04181970